Register for Virtual Events

Raphael G Ognar

I am interested in registering for all events.

Available to Club Members & Social Members

Available to Club Members ONLY

1: Deal Structure | April 3, 2024 (12-1PM ET)

Join us for Inning 1 of the BIO2024 Bullpen virtual meeting series entitled “Deal Structure”


Hour 1: Panel Discussion

The life sciences game changes constantly and so do deal structures. Keep your finger on the pulse of the market in the Bullpen.

This one-hour Panel Discussion will highlight 5-10 top advisors, bankers, investors, brokers and strategics who are closing deals today ranging from seed round to IPOs, commercial leases to licenses.

Each panelist will share real-time insights into their deal flow structure and what is driving it. They’ll tell us how they see the second half of 2024 unfolding.

M. Jaione Maiz, PhD, MBA at Anzu Partners
Salvatore Buscemi at Brahmin Partners
Ronak Savla at Catalent Pharma Solutions
Jess Hawthorne at CSC Leasing
Ann Ladd at Fredrikson & Byron, P.A.
Darwin Ling at Good AI Capital
Jinsy Jacobs Angel Investor
Phillip Ebner at J.P. Morgan
Alexis Ji at Primer Ventures
Austin Barrett at Savills

2: Pitch Deck Critique | April 10, 2024 (12-1PM ET)

Join us for Inning 2 of the BIO2024 Bullpen virtual meeting series entitled “Pitch Deck.”


Hour 1: Panel Discussion

Hey Pitchers - how confident are you in your delivery? What deck do you send for your first pitch? Are you sure it’s what investors want to see?

This one-hour Panel Discussion will highlight 5-10 top investors active in seed to late-stage deals. They will critique and rank four volunteer Club Member’s intro decks. Bring your peanuts and Cracker Jack to this one.

Each panelist will share what they hope to see in an intro deck and how much time they are willing to give your idea.

Hour 1: Panelists (5)
Pooja Majmudar, PhD | Silicon Valley Bank
Sarah Benson-Konforty, MD | 1010VC
Kristin King, MBA | Boston Harbor Angels
Tari Suprapto | Novo Nordisk
Stella K. Vnook | Likarda

Pitchers
Amy Baxter | Pain Care Labs
Anna Argo | Cytotheryx, Inc.
Elizabeth Smith | Fzata

3: Industry Partnering | April 17, 2024 (12-1PM ET)

Join us for Inning 3 of the BIO2024 Bullpen virtual meeting series entitled “Industry Partnering.”


Hour 1: Panel Discussion

Deal Makers deliver results for many different types of teams within life sciences. This week, we introduced you to several who are building the path forward by bringing us together.

This one-hour Panel Discussion highlighted 18 top accelerators, associations, non-profits, strategics, government agencies and industry groups that bring partnerships together.

Each panelist shared their unique approach and value they offer to the market.

April Wurster | Snell & Wilmer
Elyse Blazevich | Colorado BioScience Association
Mackensie Vernetti | BIO
George Eastwood | Emily Whitehead Foundation
Rachael O'Meara | SIC Venture Studio
David  Crean | Biocom California
Prasun Mishra | American Association for Precision Medicine
Tamika Jackson | SSLS, Inc.
James Cavuoto | Neurotech Reports
Paula Norbom | Talencio
Geof Hannigan | Merck Digital Sciences Studio
Teresa Henry | Sequoia Biotech Consulting
Jack Florio | NuFund Venture Group
Laura Sailor | TheraXyte
Harsha Rajasimha | IndoUSrare
Michael Hill | Science Innovations, LLC
Merom Klein | Courage Growth Partners
Maarten Rotman | Mayo Clinic

4: Non-Dilutive Funding | April 24, 2024 (12-1PM ET)

Join us for Inning 4 of the BIO2024 Bullpen virtual meeting series entitled “Non-Dilutive Funding.”


Hour 1: Panel Discussion

Non-Dilutive Funding is the warmup exercise for many life science startups…and it can come from many different sources. It puts the technology players on the field to be evaluated by the scouts.

This one-hour Panel Discussion will highlight 5-10 top advisors, non-profits and government agencies that bring equity-free funding to some the world’s most exciting life science startups.

Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Hour 2: Member Only "Magic Hour"

The 2nd hour is reserved for Bullpen Club Members only. Choose a virtual Clubhouse Room that best fits you - Drug, Device, Diagnostic or Digital. Club Members will each make introductions and have an opportunity to "ask" other Members for resources, referrals and other strategic requests.

5: Angel Funding | May 1, 2024 (12-1PM ET)

Join us for Inning 5 of the BIO2024 Bullpen virtual meeting series entitled “Angel Funding.”


Hour 1: Panel Discussion

Angels are the leadoff investors that pitchers face in the life sciences game. Join us to hear what compels Angels to divinely invest early in promising technologies and people.

This one-hour Panel Discussion will highlight 5-10 top Angel Investors willing to get the game started for some the world’s most exciting life science startups.

Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Hour 2: Member Only "Magic Hour"

The 2nd hour is reserved for Bullpen Club Members only. Choose a virtual Clubhouse Room that best fits you - Drug, Device, Diagnostic or Digital. Club Members will each make introductions and have an opportunity to "ask" other Members for resources, referrals and other strategic requests.

6: Venture & PE Funding | May 8, 2024 (12-1PM ET)

Join us for Inning 6 of the BIO2024 Bullpen virtual meeting series entitled “Venture Funding.”


Hour 1: Panel Discussion

Venture Investors swing for the fences, driving startups across home plate and scoring massive returns. However, they only will take a swing at the perfect pitch.

This one-hour Panel Discussion will highlight 5-10 top Venture Investors willing to take aggressive swings at the most exciting life science startups.

Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Hour 2: Member Only "Magic Hour"

The 2nd hour is reserved for Bullpen Club Members only. Choose a virtual Clubhouse Room that best fits you - Drug, Device, Diagnostic or Digital. Club Members will each make introductions and have an opportunity to "ask" other Members for resources, referrals and other strategic requests.

7: Strategic Funding | May 15, 2024 (12-1PM ET)

Join us for Inning 7 of the BIO2024 Bullpen virtual meeting series entitled “7: Strategic Funding.”


Hour 1: Panel Discussion

Strategic Investors are seasoned experts that bring value to the strategy in play for the entities they support. Their investment may come in many different forms: seed funding, collaborations, licensing and M&A…just to name a few.

This one-hour Panel Discussion will highlight 5-10 top Strategic Investors who take a calculated approach to funding the most exciting life science startups.Each panelist will share their investment mandate, funding processes, deal structure preferences, and 12-month outlook.

Hour 2: Member Only "Magic Hour"

The 2nd hour is reserved for Bullpen Club Members only. Choose a virtual Clubhouse Room that best fits you - Drug, Device, Diagnostic or Digital. Club Members will each make introductions and have an opportunity to "ask" other Members for resources, referrals and other strategic requests.

8: Exits: M&A and IPO | May 22, 2024 (12-1PM ET)

Join us for Inning 8 of the BIO2024 Bullpen virtual meeting series entitled “8: Exits: M&A and IPO.”


Hour 1: Panel Discussion

In the end, the scoreboard is what matters. How your company exits matters to you, your investors and your partners. Set your vision on the endgame with help from the Bullpen.

This one-hour Panel Discussion will highlight 5-10 top operators, brokers, investors and buyers who move life science startups across home plate. Each panelist will share their recent exits, the pathways they followed to get it done, deal structures, and 12-month outlook.

Hour 2: Member Only "Magic Hour"

The 2nd hour is reserved for Bullpen Club Members only. Choose a virtual Clubhouse Room that best fits you - Drug, Device, Diagnostic or Digital. Club Members will each make introductions and have an opportunity to "ask" other Members for resources, referrals and other strategic requests.

9: Pitch Competition | May 29, 2024 (12-1PM ET)

Join us for Inning 9 of the BIO2024 Bullpen virtual meeting series entitled “9: Pitch Competition.”


Join this two-hour virtual pitch event featuring 75+ Bullpen Members and their technologies in four distinct categories: Drug, Device, Diagnostic & Digital. This will be the final virtual meeting before we meet the following week in San Diego for BIO 2024 June 2 - 6.

©2024. ALL RIGHTS RESERVED.

Bullpen Logo Square